vs

Side-by-side financial comparison of Banzai International, Inc. (BNZI) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Banzai International, Inc. is the larger business by last-quarter revenue ($2.8M vs $2.0M, roughly 1.4× Roivant Sciences Ltd.). Banzai International, Inc. runs the higher net margin — -207.0% vs -13301.2%, a 13094.2% gap on every dollar of revenue. On growth, Banzai International, Inc. posted the faster year-over-year revenue change (163.2% vs -77.8%). Over the past eight quarters, Banzai International, Inc.'s revenue compounded faster (60.2% CAGR vs -73.7%).

Banzai International, Inc. is a SaaS enterprise that develops cloud-based marketing automation platforms. It primarily serves B2B clients across technology, healthcare, and financial services segments in the U.S. market, helping businesses optimize customer engagement, drive demand generation, and improve marketing campaign ROI.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

BNZI vs ROIV — Head-to-Head

Bigger by revenue
BNZI
BNZI
1.4× larger
BNZI
$2.8M
$2.0M
ROIV
Growing faster (revenue YoY)
BNZI
BNZI
+241.1% gap
BNZI
163.2%
-77.8%
ROIV
Higher net margin
BNZI
BNZI
13094.2% more per $
BNZI
-207.0%
-13301.2%
ROIV
Faster 2-yr revenue CAGR
BNZI
BNZI
Annualised
BNZI
60.2%
-73.7%
ROIV

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
BNZI
BNZI
ROIV
ROIV
Revenue
$2.8M
$2.0M
Net Profit
$-5.9M
$-265.9M
Gross Margin
81.7%
Operating Margin
-155.7%
-16966.1%
Net Margin
-207.0%
-13301.2%
Revenue YoY
163.2%
-77.8%
Net Profit YoY
61.8%
-257.0%
EPS (diluted)
$-1.64
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BNZI
BNZI
ROIV
ROIV
Q4 25
$2.0M
Q3 25
$2.8M
$1.6M
Q2 25
$3.3M
$2.2M
Q1 25
$3.4M
$-39.6M
Q4 24
$9.0M
Q3 24
$1.1M
$4.5M
Q2 24
$1.1M
$8.0M
Q1 24
$1.1M
$28.9M
Net Profit
BNZI
BNZI
ROIV
ROIV
Q4 25
$-265.9M
Q3 25
$-5.9M
$-113.5M
Q2 25
$-7.9M
$-223.4M
Q1 25
$-3.6M
$-206.5M
Q4 24
$169.4M
Q3 24
$-15.4M
$-230.2M
Q2 24
$-4.0M
$95.3M
Q1 24
$-4.3M
$-151.1M
Gross Margin
BNZI
BNZI
ROIV
ROIV
Q4 25
Q3 25
81.7%
Q2 25
83.0%
Q1 25
82.1%
Q4 24
Q3 24
68.7%
Q2 24
69.1%
Q1 24
64.7%
Operating Margin
BNZI
BNZI
ROIV
ROIV
Q4 25
-16966.1%
Q3 25
-155.7%
-19492.9%
Q2 25
-144.2%
-13130.0%
Q1 25
-145.2%
674.8%
Q4 24
-3042.6%
Q3 24
-256.5%
-7636.0%
Q2 24
-315.7%
-1279.5%
Q1 24
-315.2%
-919.5%
Net Margin
BNZI
BNZI
ROIV
ROIV
Q4 25
-13301.2%
Q3 25
-207.0%
-7225.9%
Q2 25
-243.1%
-10292.9%
Q1 25
-107.8%
521.8%
Q4 24
1878.3%
Q3 24
-1426.4%
-5143.8%
Q2 24
-370.3%
1192.7%
Q1 24
-397.4%
-522.3%
EPS (diluted)
BNZI
BNZI
ROIV
ROIV
Q4 25
$-0.38
Q3 25
$-1.64
$-0.17
Q2 25
$-4.08
$-0.33
Q1 25
$-0.15
$-0.28
Q4 24
$0.23
Q3 24
$-48.73
$-0.31
Q2 24
$-14.09
$0.12
Q1 24
$-1.64
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BNZI
BNZI
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$851.4K
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$5.4M
$4.3B
Total Assets
$33.0M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BNZI
BNZI
ROIV
ROIV
Q4 25
$4.5B
Q3 25
$851.4K
$4.4B
Q2 25
$2.3M
$4.5B
Q1 25
$780.8K
$4.9B
Q4 24
$5.1B
Q3 24
$4.3M
$5.4B
Q2 24
$471.7K
$5.7B
Q1 24
$1.0M
$6.5B
Total Debt
BNZI
BNZI
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
BNZI
BNZI
ROIV
ROIV
Q4 25
$4.3B
Q3 25
$5.4M
$4.4B
Q2 25
$3.0M
$4.3B
Q1 25
$2.9M
$4.7B
Q4 24
$5.2B
Q3 24
$-22.8M
$5.2B
Q2 24
$-31.8M
$5.4B
Q1 24
$-30.8M
$6.0B
Total Assets
BNZI
BNZI
ROIV
ROIV
Q4 25
$5.2B
Q3 25
$33.0M
$5.1B
Q2 25
$34.7M
$5.0B
Q1 25
$33.7M
$5.4B
Q4 24
$5.8B
Q3 24
$7.3M
$6.2B
Q2 24
$3.8M
$6.5B
Q1 24
$4.4M
$7.2B
Debt / Equity
BNZI
BNZI
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BNZI
BNZI
ROIV
ROIV
Operating Cash FlowLast quarter
$-4.4M
$-196.5M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BNZI
BNZI
ROIV
ROIV
Q4 25
$-196.5M
Q3 25
$-4.4M
$-185.7M
Q2 25
$-4.0M
$-204.4M
Q1 25
$-5.0M
$-172.6M
Q4 24
$-207.3M
Q3 24
$-1.6M
$-266.8M
Q2 24
$-1.7M
$-192.8M
Q1 24
$-2.1M
$-108.5M
Free Cash Flow
BNZI
BNZI
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$-193.5M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-209.1M
Q3 24
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
BNZI
BNZI
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
-12317.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
BNZI
BNZI
ROIV
ROIV
Q4 25
246.9%
Q3 25
499.6%
Q2 25
185.9%
Q1 25
-2.0%
Q4 24
20.3%
Q3 24
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
BNZI
BNZI
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BNZI
BNZI

Other$1.7M60%
Banzai Operating$1.1M40%

ROIV
ROIV

Segment breakdown not available.

Related Comparisons